Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.16 USD | -1.51% | -3.09% | -22.04% |
May. 20 | Insmed Lung Infections Treatment Study Shows Improvement | MT |
May. 15 | Goldman Sachs Adjusts Price Target on Insmed to $49 From $40, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.04% | 3.59B | |
+9.99% | 115B | |
+12.01% | 106B | |
-3.07% | 24.69B | |
-0.61% | 21.97B | |
-4.50% | 19.27B | |
-6.90% | 17.56B | |
-39.36% | 17.32B | |
+5.82% | 14.03B | |
+33.05% | 12.13B |
- Stock Market
- Equities
- INSM Stock
- News Insmed Incorporated
- Mizuho Securities Raises Price Target on Insmed to $36 From $35, Keeps Buy Rating